Lv3
248 积分 2024-05-09 加入
Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells
8天前
已完结
Anti-CD47 tri-specific killer engager enhances NK cell cytotoxicity against lung cancer
15天前
已完结
Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells
1个月前
已完结
Hepatocellular carcinoma
1个月前
已完结
A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies
1个月前
已完结
Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210
1个月前
已完结
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy
2个月前
已完结
Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments
3个月前
已完结
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
3个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
5个月前
已完结
皖公网安备34019202002308
